Loading
institutionsInstitution
Worldwide Cancer Research
A Scottish charity that funds early-stage discovery research on cancer anywhere in the world, rather than only in the UK.
Also called: Association for International Cancer ResearchAICR
Overview
Founded in 1979 in St Andrews as the Association for International Cancer Research, Worldwide Cancer Research funds curiosity-driven basic and discovery science on any cancer in any country, on the principle that discoveries come from unexpected places. Its grants typically support three-year laboratory projects at universities and institutes across Europe, North America, Australia and beyond. The charity has funded more than 2,000 projects since its founding and highlights alumni whose early work later underpinned drugs and diagnostics. It is now headquartered in Edinburgh.
Location
Edinburgh, GB
Type
consortium
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#560 · 6 points (0 Newsweek + 0 NCI + 6 from 3 linked objects) · ranking
- International discovery research grants
- Early-career and high-risk project funding
Similar pages
- IdeaPublish per-patient trial cost benchmarks and target halving them
Shares Funding follows fashion, not burden, Cancer Research UK.
- IdeaA public registry of unanswered clinical questions linked to funding calls
Shares Funding follows fashion, not burden, Cancer Research UK.
- IdeaRing-fence a fifth of national cancer research money for metastasis
Shares Funding follows fashion, not burden, Cancer Research UK.
- IdeaA public-benefit phase 1 factory that takes academic discoveries into first-in-human trials
Shares The valley of death between lab and product, Funding follows fashion, not burden.
- IdeaForty-eight-hour small grants for bold experiments in neglected cancers
Shares The valley of death between lab and product, Funding follows fashion, not burden.
- InstitutionEllison Institute of Technology
Shares The valley of death between lab and product, Funding follows fashion, not burden.
- PersonLarry Ellison
Shares The valley of death between lab and product, Funding follows fashion, not burden.
- IdeaA precompetitive consortium for the twenty hardest cancer targets
Shares Funding follows fashion, not burden, Cancer Research UK.